Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control analysis

Annals of Surgical Oncology

Volumn 20, Issue 2, 2013, Pages 482-490

  Tzeng, Ching Wei D ^a   Aloia, Thomas A ^a   Vauthey, Jean Nicolas ^a   Chang, George J ^a   Ellis, Lee M ^a   Feig, Barry W ^a   Curley, Steven A ^a   Skibber, John M ^a   Abdalla, Eddie K ^a   You, Y Nancy ^a   Rodriguez Bigas, Miguel A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

AGE; ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING; BLOOD VOLUME; BODY MASS; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CASE CONTROL STUDY; CHEMORADIOTHERAPY; COHORT ANALYSIS; COLORECTAL CARCINOMA; COMORBIDITY; CONTROLLED STUDY; GENDER; HUMAN; ILEOSTOMY; LENGTH OF STAY; LIVER RESECTION; MORBIDITY; MULTIPLE CYCLE TREATMENT; OPERATION DURATION; OVERALL SURVIVAL; PORTAL VEIN; POSTOPERATIVE COMPLICATION; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM RESECTION; RECURRENCE FREE SURVIVAL; RISK ASSESSMENT; SURGEON; SURGICAL APPROACH; SURGICAL PATIENT; SURGICAL RISK;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLECTOMY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MORBIDITY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84878864666     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2620-z     Document Type: Article

References (19)

1. Brouquet A, Mortenson MM, Vauthey JN, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg. 2010;210:934-41.
2. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg. 2006;93:872-8.
3. Verhoef C, van der Pool AE, Nuyttens JJ, Planting AS, Eggermont AM, de Wilt JH. The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum. 2009;52:23-30.
4. van der Pool AE, de Wilt JH, Lalmahomed ZS, Eggermont AM, Ijzermans JN, Verhoef C. Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg. 2010;97:383-90.
5. de Jong MC, van Dam RM, Maas M, et al. The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience. HPB (Oxford). 2011;13:745-52.
6. Mentha G, Roth AD, Terraz S, et al. "Liver first" approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg. 2008;25:430-5.
7. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009;27:3379-84.
8. Aloia TA, Zorzi D, Abdalla EK, Vauthey JN. Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg. 2005;242:172-7.
9. Smith DL, Arens JF, Barnett CC Jr, Izzo F, Curley SA. A prospective evaluation of ultrasound-directed transparenchymal vascular control with linear cutting staplers in major hepatic resections. Am J Surg. 2005;190:23-9.
10. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13.
11. Greenblatt DY, Rajamanickam V, Pugely AJ, Heise CP, Foley EF, Kennedy GD. Short-term outcomes after laparoscopic-assisted proctectomy for rectal cancer: results from the ACS NSQIP. J Am Coll Surg. 2011;212:844-54.
12. Widdison AL, Barnett SW, Betambeau N. The impact of age on outcome after surgery for colorectal adenocarcinoma. Ann R Coll Surg Engl. 2011;93:445-50.
13. Warschkow R, Steffen T, Thierbach J, Bruckner T, Lange J, Tarantino I. Risk factors for anastomotic leakage after rectal cancer resection and reconstruction with colorectostomy. A retrospective study with bootstrap analysis. Ann Surg Oncol. 2011;18:2772-82.
14. Suding P, Jensen E, Abramson MA, Itani K, Wilson SE. Definitive risk factors for anastomotic leaks in elective open colorectal resection. Arch Surg. 2008;143:907-11.
15. Brouquet A, Abdalla EK, Kopetz S, et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29:1083-90.
16. Aloia TA, Vauthey JN. Management of colorectal liver metastases: past, present, and future. Updates Surg. 2011;63:1-3.
17. Reddy SK, Pawlik TM, Zorzi D, et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol. 2007;14:3481-91.
18. Hillingso JG, Wille-Jorgensen P. Staged or simultaneous resection of synchronous liver metastases from colorectal cancer - a systematic review. Colorectal Dis. 2009;11:3-10.
19. Chun YS, Vauthey JN, Ribero D, et al. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg. 2007;11:1498-504.